Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancer

Phase I trial of dose-escalated stereotactic radiosurgery (SRS) boost for unfavorable locally advanced oropharyngeal cancer

Abstract Background and purpose Patients with locally advanced oropharynx squamous cell carcinoma have suboptimal outcomes with standard chemoradiation. Here, we evaluated toxicity and oncologic outcomes of dose escalation using radiosurgical boost for patients with unfavorable oropharynx squamous c...

Full description

Bibliographic Details
Main Authors: Prashant Vempati, Aditya N. Halthore, Sewit Teckie, Zaker Rana, Emile Gogineni, Jeffrey Antone, Honglai Zhang, Mihaela Marrero, Kristin Beadle, Douglas K. Frank, Mohamed Aziz, Doru Paul, Maged Ghaly
Format: Article
Language:English
Published: BMC 2020-12-01
Series:Radiation Oncology
Subjects:
Radiosurgery
SRS
Dose escalation
Oropharynx
Head-and-neck
Online Access:https://doi.org/10.1186/s13014-020-01718-w

Internet

https://doi.org/10.1186/s13014-020-01718-w

Similar Items